Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Current Leases (2019 - 2025)

Perspective Therapeutics (CATX) has disclosed Current Leases for 7 consecutive years, with $623000.0 as the latest value for Q4 2025.

  • Quarterly Current Leases fell 34.9% to $623000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $623000.0 through Dec 2025, down 34.9% year-over-year, with the annual reading at $623000.0 for FY2025, 34.9% down from the prior year.
  • Current Leases hit $623000.0 in Q4 2025 for Perspective Therapeutics, down from $704000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $980000.0 in Q1 2025 to a low of $46000.0 in Q4 2023.
  • Historically, Current Leases has averaged $450736.8 across 5 years, with a median of $272000.0 in 2022.
  • Biggest YoY gain for Current Leases was 1980.43% in 2024; the steepest drop was 54.29% in 2024.
  • Year by year, Current Leases stood at $260000.0 in 2021, then grew by 4.62% to $272000.0 in 2022, then plummeted by 83.09% to $46000.0 in 2023, then soared by 1980.43% to $957000.0 in 2024, then crashed by 34.9% to $623000.0 in 2025.
  • Business Quant data shows Current Leases for CATX at $623000.0 in Q4 2025, $704000.0 in Q3 2025, and $847000.0 in Q2 2025.